原著論文
2026 Do the treatment selection factors emphasized in clinical guidelines—Chronic kidney disease, cardiovascular disease, and heart failure—contribute to the risk of urinary tract infections during the administration of sodium-glucose cotransporter-2 inhibitors? : Koinuma T, Yoshida M, Akazawa M, Journal of Diabetes Investigation , 17, 1489–1498 (2026) Longitudinal Changes in Utility Scores and Health-Related Quality of Life During Interferon-Free Direct-Acting Antiviral Therapy for Chronic Hepatitis C in Japan: Implications for Cost–Utility Analysis : Hirao M, Sugimori H, Igarashi A, Yatsuhashi H, Satoh T, Ikeda S, Masaki N, Yotsuyanagi H, Takura T, Yoda T, Akazawa M, Suka M, Ito N, Odajima T and Hirao T, Livers 2026, 6, 78 ペムブロリズマブの適応拡大に伴う副作用自発報告の変遷についての実態調査：山本 夏菜、酒井 良子、赤沢 学、YAKUGAKU ZASSHI 146, 533–539 (2026) Risk factors of serious infections in patients with large-vessel vasculitis after the approval of tocilizumab in 2017: a retrospective nested case-control study using the Japanese health insurance database : Horiuchi S, Kudo K, Kawano K, Sugihara T, Nakaoka Y, Sakai R and Akazawa M, Research & Therapy (2026) 28:82 AYA世代膠原病患者との治療目標共有に 向けた患者と医療従事者の役割に関する文献調査：齋藤 結衣、 酒井 良子、赤沢 学、日本ヘルスコミュニケーション学会誌第 17 巻第 1 号 (2026) Investigation of Risk Factors for Discontinuation of Pregabalin in Cancer-related Neuropathic Pain : Tajima S, Yamaguchi M, Shouho C, Toga C, Chinzei M, Yoshida T, Sakai R, Akazawa M, 日本緩和医療薬学雑誌(Jpn.J. Pharm. Palliat. Care Sci.) 19:20-26 (2026) Risk factors of serious infections in patients with largevessel vasculitis after the approval of tocilizumab in 2017: a retrospective nested case-control study using the Japanese health insurance database : Horiuchi S, Kudo Y, Kawano K, Sugihara T, Nakaoka Y, Sakai R, Akazawa M, Arthritis Research & Therapy, 28, 82 Assessment of the Utilization of Sodium–Glucose Cotransporter-2 Inhibitors in Patients Without Diabetes：Koinuma T, Yoshida M, and Akazawa M, Pharmacoepidemiology 2024, 3, 383–393 2025 Societal cost-of-illness analysis of self-injection of biologics for patients with rheumatoid arthritis in Japan using claims, surveys, and national statistics：Takahata K, Tanaka E, Sakai R and Akazawa M, Health Economic Review, 15, 106 Temporal trends in the prescription of biosimilars and the status of switching from original biologics to biosimilars at individual and institutional levels in Japan：Matsumoto M, Kumazawa R, Ishii-Watanabe A, Horiguchi I, Mamiya H, Shibata H, Saito Y, Adomi M, Taniguchi Y, Komiyama J Sakai R and Iwagami M, Ther Innov Regul Sci, 59, 1276-1287 Time trends in the prescription of sodium-glucose co-transporter-2 inhibitors based on a claims database in Japan from 2014 to 2022: expanded use in older adults, those with comorbidities, and those potentially initiating diabetes treatment：Koinuma T, Yoshida M and Akazawa M, Diabetol Int, 17, 4 Comparative Clinical Practice of Juvenile Idiopathic Arthritis and Rheumatoid Arthritis in Adolescents and young Adults: A Retrospective Cohort Study Using Japanese Health Insurance Claims Data (2016-2020)：Miyamae T, Sakai R, Inoue Y, Kato D, Inoue E, Hirano T, Izawa K, Kishida D, Matsushita M, Mitsunaga K, Mori Mj, Narazaki H, Nishikomori R, Shimizu M, Sugihara T, Sumitomo S, Tanaka T, Yamazaki S, Yamaji K, Yokogawa N, Yoshifuji H, Tanaka E and Harigai M, Mod Rheumatol, 35, 935-943 Verification of unmet medical needs in patients with juvenile idiopathic arthritis in Japan：Shimizu M, Inoue E, Sakai R, Inoue Y, Mitsunaga K, Sugihara T, Hirano T, Izawa K, Kishida D, Matsushita M, Mori M, Narazaki H, Nishikomori R, Sumitomo S, Tanaka T, Yamazaki S, Yamaji K, Yokogawa N, Yoshifuji H and Miyamae T, Mod Rheumatol , 35, 909-915 Prevalence of systemic lupus erythematosus and age-stratified treatment trends in the Japanese population: a cross-sectional study based on the National Database of Health Insurance Claims：Matsushita M, Sakai R, Yokogawa N, Shimizu M, Inoue Y, Inoue, Yamaji K, Mori M and Miyamae T, Mod Rheumatol, 35, 850-858 Nationwide epidemiological survey of primary Sjogren’s disease in Japan using the National Database of Designated Intractable Diseases：Inoue Y, Sakai R, Inoue E, Mitsunaga K, Yamaji K, Mori M, Tomiita M, Shimojo N and Miyamae T, Mod Rheumatol, 35, 859-865 Cost-Effectiveness Analysis of First-Line Chemotherapy for Metastatic Pancreatic Cancer in Japan：Sasahara Ya, Takumoto Y, Murata Tb, Akazawa M and Narimatsu H, Cancer Med, 14, e71233 Evaluation of Data Quality and Utility of the Japan Drug Information Institute in Pregnancy (JDIIP) Consultation Case Database for Pregnancy Pharmacovigilance：Takumoto Y, Ohba A, Terashima T, Ueno M, Ikezawa K, Okano N, Okusaka T, Morizane C, Ikeda M, Ozaka M, Narimatsu H, Akazawa M, Shiroiwa Ta and Furuse J, Cancer Med, 14, e71161 Evaluation of Data Quality and Utility of the Japan Drug Information Institute in Pregnancy (JDIIP) Consultation Case Database for Pregnancy Pharmacovigilance：Matsuda S, Yakuwa N, Goto M, Akazawa M, Takahashi K, Anzai T, Koinuma S, Fujioka I, Miura Y, Ota M, Oka H, Nitani N, Tawaragi T and Murashima A, Drug Saf, 48, 1035-1046 Evaluating the Potential of Prevalent New User Design as an Alternative When New User Design is Impractical：Koinuma T and Akazawa M, Pragmat Obs Res, 16, 155-168 Vancomycin-associated acute kidney injury and its clinical and economic impact: a retrospective cohort study using two Japanese healthcare databases：Murakami Sa, Ishiyama A, Otogawa S, Sakai R and Akazawa M, J Infect Chemother, 31, 102744 Differences in asthma-related outcomes by anti-IL-5 biologics, omalizumab, and dupilumab based on blood eosinophil counts：Kimura Y, Suzukawa M, Inoue N, Imai S, Horiguchi H, Akazawa M and Matsui H, Asian Pac J Allergy Immunol, 43, 290-299 Health economic evaluation of self-injection of biologics in patients with rheumatoid arthritis using a Japanese real-world web-based survey：Takahata K, Maeda Y, Tanaka E, Sakai R and Akazawa M, BMC Health Serv Res, 25, 730 Persistence and adherence to sodium-glucose co-transporter 2 inhibitor monotherapy among patients with type 2 diabetes mellitus: a retrospective study based on a Japanese claims database：Mukai Ja, Akazawa M, Yoshiyama Yb and Kubota R, Diabetol Int, 16, 559-567 Current status and challenges of health economic evaluations related to antimicrobial stewardship in Japan: A scoping review up to 2023：Goto R, Inose R, Shoji T, Akazawa M and Muraki Y, J Infect Chemother, 31, 102657 Trends in syphilis treatments and the impact of intramuscular injectable Benzathine penicillin G in Japan: A descriptive study using administrative claims data from April 2016 to September 2023：Shoji T, Akazawa M, Inoue O and Suzuki T, J Infect Chemother, 31, 102586 Nationwide epidemiological survey of juvenile idiopathic arthritis during transition to young adulthood in Japan using the National Database of Designated Incurable Diseases of Japan：Inoue Y, Sakai R, Inoue E, Mitsunaga K, Shimizu M, Sugihara T, Matsushita M, Yamaji K, Mori M, Shimojo N and Miyamae T, Mod Rheumatol, 35, 359-365 Delayed global standardization and prefectural disparities in systemic lupus erythematosus treatment in Japan: a nationwide study using the National Database oh Health Insurance Claims and Specific Health Checkups of Japan：Yokogawa N, Sakai R, Matsushita M, Shimizu M, Inoue Y, Inoue E, Yamaji K, Mori M and Miyamae T, Mod Rheumatol, 35, 294-299 Cost-effectiveness of systematic chemotherapy for metastatic pancreatic cancer: a retrospective study using Japanese clinical data：Shinohara Aa, Takumoto Y, Tauchi Ja, Morishita Ka, Kawasaki Ta and Akazawa M, Sci Rep, 15, 267 Trends of Strong and Weak Opioid Prescriptions in Japan: A Cross-Sectional Study Based on Open Data from the National Database and Hospital Claims Data from Fiscal Years 2015 to 2021：Shoji T, Akazawa M, Nakagomi N, Kobayashi M, Kitta F, Inose R, Muraki Y, Iijima T and Suzuki T, Biol Pharm Bull, 48, 279-285 Increased risk of cardiovascular events under the treatments with Janus kinase inhibitors versus biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a retrospective longitudinal population-based study using the Japanese health insurance database：Ryoko Sakai, Eiichi Tanaka, Eisuke Inoue, Masayoshi Harigai RMD, 2024 Jun 17;10(2):e003885. doi: 10.1136/rmdopen-2023-003885. 薬物治療中に複数施設を受診する疾患の安全性情報収集におけるレセプトデータベースの適用可能性の検討：堀内沙莉、赤沢学、薬剤疫学、30、1-11
2024 Assessment of the Utilization of Sodium–Glucose Cotransporter-2 Inhibitors in Patients Without Diabetes ： Koinuma T, Yoshida M, and Akazawa M, Pharmacoepidemiology., 3, 383-393 Quality-of-life survey of pancreatic cancer patients: a comparison between general public and physicians : Sasahara Y, Takumoto Y, Watanabe K, Takeda H, Umemoto K, Sunakawa Y, Suzuki N, Yoshioka T, Kobayashi S, Ueno M, Nakamura S, Akazawa M and Narimatsu H. Front Health Serv. 4, 1275496 Comparative Effectiveness of Long-Acting Injectable Versus Oral Antipsychotics in Patients With Schizophrenia Using the Prevalent New User Design and Subgroup Analyses: Okada Y, Inada K, Akazawa M. J Clin Psychopharmacol. 44, 263-271 Factors Related to Treatment Non-Adherence Among Caregivers of Pediatric and Adolescent Growth Hormone Deficiency Patients in Japan：Manabu Akazawa, Takahiro Sato, Nozomi Ebata, Michael LoPresti , Ryosuke Nishi . Patient Preference and Adherence , 18, 607-622 Risk of hospitalized infections in older elderly patients with rheumatoid arthritis treated with tocilizumab or other biological/targeted synthetic disease-modifying antirheumatic drugs: Evaluation of data from a Japanese claims database ： Harigai M, Fujii T, Sakai R, Igarashi A, Shoji A, Yamaguchi H, Iwasaki K, Makishima M, Yoshida A, Okada N, Yamashita K and Kawahito Y, Mod Rheumatol, 34, 287-296 (2024) Epidemiology of chronic pulmonary aspergillosis: A nationwide descriptive study ： Kimura Y, Sasabuchi Y, Jo T, Hashimoto Y, Kumazawa R, Ishimaru M, Matsui H, Yokoyama A, Tanaka G and Yasunaga H, Respir Investig, 62, 1102-1108 (2024) Association of Novel Antihyperglycemic Drugs Versus Metformin With a Decrease in Asthma Exacerbations ： Kimura Y, Jo Tb, Inoue N, Suzukawa M, Hashimoto Y, Kumazawa R, Ishimaru M, Matsui H, Yokoyama A, Tanaka G, Sasabuchi Y and Yasunaga H, J Allergy Clin Immunol Pract, 12, 2035-2044 (2024) Annual trends in atypical hemolytic uremic syndrome management in Japan and factors influencing early diagnosis and treatment: a retrospective study ：Tatematsu Y, Imaizumi T, Michihata N, Kato Na, Kumazawa R, Matsui H, Fushimi K, Yasunaga H and Maruyama S, Sci Rep, 14, 18265 (2024) Epidemiology of patients with lymphangioleiomyomatosis: A descriptive study using the national database of health insurance claims and specific health checkups of Japan : Kimura Y, Jo T, Hashimoto Y, Kumazawa R, Ishimaru M, Matsui H, Yokoyama A, Tanaka G and Yasunaga H, Respir Investig, 62, 494-502 (2024) Antiemetic Effect of Rikkunshito, a Japanese Kampo Herbal Medicine, on Cisplatin-induced Nausea And Vomiting: A Nationwide Database Study In Japan:Jo T, Shigemi D, Konishi T, Yamana H, Michihata N, Kumazawa R, Yokoyama A, Urushiyama H, Matsui H, Fushimi K, Nagase T and Yasunaga H, Intern Med, 63, 919-927 Cilostazol versus aspirin or clopidogrel for reducing post-stroke aspiration pneumonia: A nationwide retrospective cohort study : Sato S, Yamana H, Kumazawa R, Watanabe H, Fujita A, Matsui H, Fushimi K and Yasunaga H, Cerebrovasc Dis, 53, 152-159
2023 Difference between days of therapy and days of antibiotic spectrum coverage in an inpatient antimicrobial stewardship program: Vector autoregressive models for time-series analysis：Shutaro Murakami, Manabu Akazawa, Hitoshi Honda, Infection Control&HospitalEpidemiology (2023), 1–8 , doi: doi:10.1017/ice.2023.197. 医療機関における医薬品採用と適正使用に関する実態調査 2020：金井 紀仁, 此村 恵子, 上田 彩, 王 君茹, 大塚 麻柚, 赤沢 学、 医薬品情報学、2023 年 25 巻 1 号 p. 12-23 Treatment patterns and cost estimations of systemic chemotherapy for pancreatic cancer in Japan: A retrospective database study：Yuki Takumoto, Ryotaro Shibahara, Hajime Asami, Manabu Akazawa, Cancer Med . 2023 May 18, doi: 10.1002/cam4.6100. Online ahead of print. Comparative effectiveness of long-acting injectable antipsychotics in patients with schizophrenia in Japan：Yusuke Okada, Ken Inada, Manabu Akazawa, Schizophr Res . 2023 Feb252:300-308. doi: 10.1016
2022 Estimated medical costs of methicillin-resistant Staphylococcus aureus infection classified by polymerase chain reaction-based open reading frame typing in Japan：Shoji T, Muto R, Sakai R, Matsumura H, Uchida T, Kitta F, Inoue O, Kawata K, and Akazawa M, AIMS Microbiology, 8(4): 528–543.doi: 10.3934/microbiol.2022034 Health state utility values for metastatic pancreatic cancer using a composite time trade-off based on the vignette-based approach in Japan ：Takumoto Y, Sasahara Y, Narimatsu H, Murata T, Akazawa M, Health Economics Review, 2022 Dec 24;12(1):63. doi: 10.1186/s13561-022-00413-8. Survey of Anaphylaxis during Rasburicase Re-Administration in Patients with Hematological Malignancies Using a Japanese Claims Database ：Kobayashi S, Yasu T, Akazawa M, Current Oncology , 2022, 29, 9826–9832. doi: 10.3390/curroncol29120772. 薬局業務の変化が薬局薬剤師の需要へ与える影響 ：此村恵子，森井康博，赤沢学、薬学雑誌、142、413-420(2022) Changes in intravenous and oral antimicrobial prescriptions during the coronavirus disease 2019 (COVID-19) pandemic: an experience at a tertiary-care center : Murakami S, Takamatsu A, Akazawa M, Goto T, Miwa T, Terayama Y, Honda H, Antimicrob Steward Healthc Epidemiol, 2022 Apr 5;2(1):e53. doi: 10.1017/ash.2022.42. eCollection 2022. PMID: 36483370 地域包括ケア時代の臨床研究を担う人材の育成：赤沢学、薬学雑誌、142、215-218(2022) Clinical Implication of the Relationship between Antimicrobial Resistance and Infection Control Activities in Japanese Hospitals: A Principal Component Analysis-Based Cluster Analysis ： Shoji T, Sato N, Fukuda H, Muraki Y, Kawata K, Akazawa M, Antibiotics, 2022, 11(2), 229 Effects of medical service fee revision on reducing irrational psychotropic polypharmacy in Japan: an interrupted time‑series analysis ：Okada Y, Akazawa M, Soc Psychiatry Psychiatr Epidemiol . 2022; 57(2): 411–422. Published online 2021 Jul 31.
2021 A Claims-Based Cohort Study on the Treatment Patterns of Japanese Patients with Type 2 Diabetes Mellitus and the Association of Early First Physician Visit with Time to Prescription of Oral Hypoglycemic Agents Watada H, Kawakita Y, Tanaka K, Oh A, Nishigaki N, Nakajima T, Fujikawa K , Akazawa M ,Diabetes Ther , 12, 2035-2047 Real-world benefits of biologics for asthma: Exacerbation events and systemic corticosteroid use, Kimura Y, Suzukawa M, Inoue N, Imai S, Akazawa M, Matsui H, World Allergy Organ J , 14, 100600 Estimation of the cost of influenza antiviral medication guidance or support provided by healthcare professionals : a questionnaire survey in Japan : Kurazono K, Ikeoka H, Hiroi S, Iwasaki K, Takeshima T, Akazawa M, J Med Econ , 25, 38-50 Assessment of the potential impact of resolving drug-related problems by clinical pharmacists in Japan: a retrospective observational study : Oki T, Ishii S, Furukawa K, Shono A, Akazawa M, J Pharm Health Care Sci, 7, 47 Relationships between developmental strategies for additional indications and price revisions for anticancer drugs in Japan : Maeda H, Okabe A, Sakakura K, Ng DB, Akazawa M, BMC Health Serv Res, 21, 1329 Methotrexate投与関節リウマチ患者における 生物学的製剤併用時の感染リスクに関するPropensity Scoreを 用いた複数の疫学的方法の妥当性の検討：鯉沼卓真、赤沢学、薬剤疫学J-STAGE、26、27-40 Interrupted time-series analyses of routine vaccination program for elderly pneumonia patients in Japan; an ecological study using aggregated nationwide inpatient data： Kobayashi K, Jo T, Mimura W, Suzukawa M, Ohshima N, Tanaka G, Akazawa M, Matsui H, Fushimi K, Yasunaga H, Nagase T, Nagai H, Hum Vaccin Immunother , Apr 20;1-9 Increased nutrition‑related risk as an independent predictor of the incidence of hypoglycemia in the hospitalized older individuals with type 2 diabetes: a single‑center cohort study：Kimura Y, Kimura N, Akazawa M, Diabetol Int , 12, 420-429
2020 Folic acid prescribed to prenatal and postpartum women who are also prescribedantiepileptic drugs in Japan: Data from a health administrative database：Ishikawa T,Obara T, Jin K, Nishigori H, Miyakoda K, Akazawa M, Nakasato N, Yaegashi N, Kuriyama S, Mano N,Birth Defects Res, 112(16), 1224-1233(2020) Prescription reviews of hospitalized and discharged patients to assess and improve polypharmacy management: Oki T, Saito A, Shono A, Sato H, Akazawa M, 医薬品相互作用研究,44(2), 18-26(2020) Reduction in the doses of direct oral anticoagulants and risk of ischemic stroke events:A hospital survey: Ueda A, Toki S, Kitayama C, Akazawa M, Biol Pharm Bull, 43(7), 1135-1140(2020) Antimicrobial utilization and antimicrobial resistance in patients with haematologicalmalignancies in Japan: a multi-centre cross-sectional study:Mimura W, Fukuda H, Akazawa M, Ann Clin Microbiol Antimicrob, 19(1):7 (2020) Antidepressant prescriptions for prenatal and postpartum women in Japan: A healthadministrative database study: Ishikawa T, Obara T, Kikuchi S, Kobayashi N, Miyakoda K,Nishigori H, Tomita H, Akazawa M, Yaegashi N, Kuriyama S, Mano N, J Affect Disord. 264:295-303(2020)
2019 Characteristics and Early Hypoglycemic Medications of Patients at Risk of Progressionto Type 2 Diabetes in Japan：Kanai N, Shono A, Kushiyama A, Akazawa M, A RetrospectiveCohort Study of Health Checkup and Claims Data. Biol Pharm Bull, 42(12), 2016-2023(2019) The Association Between Internet Searches and Moisturizer Prescription in Japan:Retrospective Observational Study： Mimura W, Akazawa M, JMIR Public Health Surveill, 5(4),e13212(2019) A Cost-Effectiveness Analysis Of Pregabalin For The Treatment Of Patients With ChronicCervical Pain With A Neuropathic Component In Japan：Akazawa M, Igarashi A, Ebata N,Murata T, Zeniya S, Haga Y, Nozawa K, Fujii K, Taguchi T,J Pain Res, 12, 2785-2797(2019) A Retrospective Evaluation of the Impact of Multi-disciplinary Approach for Improvingthe Quality of Anticoagulation Therapy in Ambulatory Patients with Non-valvular AtrialFibrillation Receiving Warfarin：Ohgushi A, Nakayama N, Namiki A, Nagashima A, Ogawa R, Akazawa M, Echizen H, Yakugaku Zasshi, 139(9), 1177-1183(2019) Validity of administrative database detection of previously resolved hepatitis B virus inJapan： Imai S, Yamana H, Inoue N, Akazawa M, Horiguchi H, Fushimi K, Migita K, Yatsuhashi H,Sugiyama M, Mizokami M: Med Virol , 91(11), 1944-1948(2019) Patterns of drug treatment in patients with osteoarthritis and chronic low back pain inJapan: a retrospective database study： Akazawa M, Mimura W, Togo K, Ebata N, Harada N,Murano H, Abraham L, Fujii K: J Pain Res, 12, 1631-1648 (2019) Examination of the prescription of antiepileptic drugs to prenatal and postpartumwomen in Japan from a health administrative database : Ishikawa T, Obara T, Jin K,Nishigori H, Miyakoda K, Suzuka M, Ikeda-Sakai Y, Akazawa M, Nakasato N, Yaegashi N, KuriyamaS, Mano N : Pharmacoepidemiol Drug Saf, 28(6), 804-811 (2019) 全国薬学部・薬科大学における薬物療法の経済評価手法に対する教育の実態調査：柳奈津代、赤沢学、社会薬学、38(1)、20-26 (2019)
2018 Applying the Lists of Risk Drugs for Thai Elderly(LRDTE)as a mechanism to account forpatient age and medicine severity in assessing potentially inappropriate medication use：Prasert V, Akazawa M, Shono A, chanjaruporn F, Ploylearmsang C, Muangyim K, Wattanapongsatit T, Sutin U, Research in Social and Administrative Pharmacy,14,451-458(2018) Identifying drug substances of screening tool for older persons' appropriateprescriptions for Japanese：Nomura K, Kojima T, Ishii S, Yonekawa T, Akishita M, Akazawa M：BMC Geriatics,18,154(2018) Establishing a Pharmacy-Based Patient Registry System: A Pilot Study for EvaluatingPharmacist Intervention for Patients with Long-Term Medication Use：Akazawa M, MikamiA, Tamura Y, Yanagi N, Yamamura S, Ogata H, Pharmacy, 6,
2017 The 23-valent pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis: a double-blinded, randomized, placebo-controlled trial：Izumi Y, Akazawa M, Akeda Y, Tohma S, Hirano F, Ideguchi H, Matsumura R, Miyamura T, Mori S, Fukui T, Iwanaga N, Jiuchi Y, Kozuru H, Tsutani H, Saisyo K, Sugiyama T, Suenaga Y, Okada Y, Katayama M, Ichikawa K, Furukawa H, Kawakami K, Oishi K, Migita K , Arthritis Res Ther, 19, 15 (2017) Applying the Lists of Risk Drugs for Thai Elderly (LRDTE) as a mechanism to account for patient age and medicine severity in assessing potentially inappropriate medication use：Prasert V, Akazawa M, Shono A, Chanjaruporn F, Ploylearmsang C, Muangyim K, Wattanapongsatit T, Sutin U, Res Social Adm Pharm, pii: S1551-7411(17)30497-7 (2017) Development of a chronic obstructive pulmonary disease severity classification system using a Japanese health insurance claims database： Konomura K, Nagai H, Akazawa M, Journal of Ageing Research and Healthcare, 2, 1-12 (2017) Economic burden of community-acquired pneumonia among elderly patients: a Japanese perspective： Konomura K, Nagai H, Akazawa M, Pneumonia , 9,19 (2017) 薬物乱用防止教室と学校外における他者への会話との関連：岩渕あずさ、庄野あい子、赤沢 学、社会薬学、36、88-92（2017）
2016 Risk of major bleeding at different PT-INR ranges in elderly Japanese patients with non-valvular atrial fibrillation receiving warfarin : a nested case-control study : Ohgushi A, Ohtani T, Nakayama N, Asai S, Ishii Y, Namiki A, Akazawa M, Echizen H, J Pharm Health Care Sci, 2, 2 (2016) 医薬品の採用と適正使用に関する調査2015：此村恵子、金井紀仁、上田 彩、草間真紀子、赤沢 学、臨床薬理、47、189-199（2016）
2015 Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus: Migita K, Akeda Y, Akazawa M, Tohma S, Hirano F, Ideguchi H, Matsumura R, Suematsu E, Miyamura T, Mori S, Fukui T, Izumi Y, Iwanaga N, Tsutani H, Saisyo K, Yamanaka T, Ohshima S, Sugiyama T, Kawabe Y, Katayama M, Suenaga Y, Okamoto A, Ohshima H, Okada Y, Ichikawa K, Yoshizawa S, Kawakami K, Matsui T, Furukawa H, Oishi K, Arthritis Res Ther,17, 149 (2015) Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients: Migita K, Akeda Y, Akazawa M, Tohma S, Hirano F, Ideguchi H, Kozuru H, Jiuchi Y, Matsumura R, Suematsu E, Miyamura T, Mori S, Fukui T, Izumi Y, Iwanaga N, Tsutani H, Saisyo K, Yamanaka T, Ohshima S, Mori N, Matsumori A, Takahi K, Yoshizawa S, Kawabe Y, Suenaga Y, Ozawa T, Hamada N, Komiya Y, Matsui T, Furukawa H, Oishi K, Arthritis Res Ther, 17:357 (2015) Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan: Igarashi A, Akazawa M, Murata T, Taguchi T, Sadosky A, Ebata N, Willke R, Fujii K, Doherty J, Kobayashi M, Clinicoecon Outcomes Res, 7:505-20 (2015) 学生の視点に合わせた「喫煙・飲酒薬物乱用防止教育」を実践するために: 川村香織、中野翔太、庄野あい子、赤沢 学、社会薬学、34、128-131 (2015)
2014 Considering economic analyses in the revision of the preventive vaccination law: A new direction for health policy-making in Japan?: Akazawa M, C Yongue J, Ikeda S, Satoh T, Health Policy, 118(1), 127-34 (2014)
2013 Assessment of statin-associated muscle toxicity in Japan: a cohort study conducted using claims database and laboratory information: Chang CH, Kusama M, Ono S, Sugiyama Y, Orii T, Akazawa M, BMJ Open, 3, e002040 (2013) Economic impact of switching to fixed-dose combination therapy for Japanese hypertensive patients: a retrospective cost analysis: Akazawa M, Fukuoka K, BMC Health Serv Res, 13, 124-132 (2013) Polypharmacy and adverse drug reactions in Japanese elderly taking antihypertensives: a retrospective database study: Sato I, Akazawa M, Drug, Healthcare and Patient Safety, 5, 143-150 (2013) 医療情報データベースを用いた副作用定義の妥当性評価－スタチン系高脂血症用剤の副作用を例として－：此村恵子、赤沢 学、臨床薬理、44、193-200 (2013)
2012 Drug utilization reviews by community pharmacists in Japan: Identification of potential safety concerns through the Brown Bag program: Akazawa M, Nomura K, Kusama M, Igarashi A, Value in Health Regional Issues , 1, 98-104 (2012) 医療機関における採用医薬品集作成と医薬品採否に関する実態調査－過去10年間の変遷を踏まえて－：草間真紀子、赤沢 学、津谷喜一郎、臨床薬理、43、43-49（2012） 英国における地域薬剤師の高度業務から学ぶブラウンバッグ運動の新しい方向性－リスクコミュニケーションへの応用－：赤沢 学、野村香織、 医薬品情報学、14，69-74 (2012)
2011 水痘ワクチンの定期接種化に関する医療経済分析：須賀万智、赤沢 学、池田俊也、五十嵐中、小林美亜、佐藤敏彦、白岩 健、杉森裕樹、田倉智之、種市摂子、平尾智広、和田耕治、厚生の指標、58、15-22（2011） インターネットで個人輸入した医薬品の保健衛生(2)－抗肥満薬による追跡－：木村和子、本間隆之、谷本 剛、高尾知里、奥村順子、吉田直子、赤沢 学、医療と社会、21、pp.55-67 (2011)